logo
logo
Sign in

The Global Tamiflu (Oseltamivir Phosphate) Market Growth Accelerated By Increasing Prevalence Of Influenza Virus Infections

avatar
Mia Yates
The Global Tamiflu (Oseltamivir Phosphate) Market Growth Accelerated By Increasing Prevalence Of Influenza Virus Infections

Tamiflu (Oseltamivir Phosphate), which is an antiviral medication used for the treatment and prevention of influenza A and influenza B, is prescribed around the world to reduce the severity and the duration of flu symptoms, as well as reducing the chances of developing complications such as bronchitis and sinusitis. Tamiflu works by blocking an enzyme that helps influenza viruses reproduce in the body, thereby stopping viral replication.

The global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 464.4 Mn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing prevalence of influenza virus infections globally is the primary factor responsible for driving the growth of the Tamiflu (Oseltamivir Phosphate) Market. According to the World Health Organization (WHO), approximately 1 billion people get infected with the influenza virus annually. Prominent key players operating in the market are focused on bringing more efficient and cost-effective Tamiflu drugs, which in turn will accelerate the growth of the Tamiflu (Oseltamivir Phosphate) Market over the forecast period.


Segment Analysis

Tamiflu (Oseltamivir Phosphate) Market can be segmented into Capsules and Oral Solution on the basis of drug type.Capsules sub-segment dominates the market as it has ease of availability and can be stored easily for longer duration compared to Oral Solution which has shorter shelf life and needs to be refrigerated.Key factors driving the capsules segment is convenience in storing and administration which makes it more suitable for home care settings and self-administration during viral epidemics and pandemics.

Key Takeaways

The Global Tamiflu (Oseltamivir Phosphate) Market Size is expected to witness high growth over the forecast period owing to increasing prevalence of viral epidemics and pandemics globally. The global Tamiflu (Oseltamivir Phosphate) Market is estimated to be valued at US$ 464.4 Mn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030.


Regional analysis for Tamiflu (Oseltamivir Phosphate) market comprises:

North America is expected to be the fastest growing region due to increasing healthcare expenditure and rising importance given to seasonal influenza treatment and stockpiling of anti-viral drugs. Asia Pacific is also emerging as a lucrative region owing to growing middle class population and investments in healthcare sector by governments of emerging economies like India, China etc.

Key players:

Key players operating in the Tamiflu (Oseltamivir Phosphate) market are Roche Holding AG, Dr. Reddy's Labs, Mylan Pharmaceuticals, and Glenmark Pharmaceuticals. Roche dominates the market due to being the innovator and original manufacturer of oseltamivir having patent protection initially. Generic versions by other companies are gaining market share as patents expire globally.

For More Insights, Read: https://www.newswirestats.com/tamiflu-oseltamivir-phosphate-market-size-share-and-growth-forecast-2023-2030/


collect
0
avatar
Mia Yates
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more